Gland Chemicals Private Limited

Form 483 issued August 7, 2018 · Waluj, India

Observations
6
Pages
4
FEI number
3003983454

In short: On August 7, 2018, FDA issued a Form 483 with 6 observations to Gland Chemicals Private Limited in Waluj, Maharashtra (FEI 3003983454). The investigator was Anastasia M. Shields. Most observations concern production and laboratory controls.

At a glance

Production and laboratory controls account for 4 of 6 observations.

Production2
Laboratory controls2
Quality system1
Other1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The Quality Unit failed to complete a satisfactory evaluation before release of…

  2. 02

    In-process materials are not tested for identity, strength, quality, purity and approved or rejected by the…

  3. 03

    The Quality Unit did not ensure that there is stability data to support retest or expiry…

  4. 04

    The master production and control records are deficient in that they do not include complete…

2 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Gland Chemicals Private Limited?

FDA listed 6 observations on this Form 483, mostly about production, laboratory controls and quality system. The opening words of each observation are shown on this page.

Who inspected Gland Chemicals Private Limited?

Anastasia M. Shields is named on this Form 483. Each investigator has a profile showing what they cite most.

When was Gland Chemicals Private Limited inspected by FDA?

This Form 483 is dated August 7, 2018.

How do I get the full Form 483 for Gland Chemicals Private Limited?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free